RhumbLine Advisers’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-548
| Closed | -$77K | – | 3324 |
|
|
2022
Q1 | $77K | Buy |
548
+62
| +13% | +$8.71K | ﹤0.01% | 2936 |
|
|
2021
Q4 | $83K | Sell |
486
-14
| -3% | -$2.39K | ﹤0.01% | 2956 |
|
|
2021
Q3 | $249K | Buy |
500
+30
| +6% | +$14.9K | ﹤0.01% | 2841 |
|
|
2021
Q2 | $235K | Buy |
+470
| New | +$235K | ﹤0.01% | 2877 |
|
|
2019
Q2 | – | Sell |
-366
| Closed | -$62K | – | 3031 |
|
|
2019
Q1 | $62K | Sell |
366
-7
| -2% | -$1.19K | ﹤0.01% | 2907 |
|
|
2018
Q4 | $44K | Buy |
373
+132
| +55% | +$15.6K | ﹤0.01% | 2952 |
|
|
2018
Q3 | $37K | Buy |
241
+8
| +3% | +$1.23K | ﹤0.01% | 2913 |
|
|
2018
Q2 | $154K | Buy |
+233
| New | +$154K | ﹤0.01% | 2800 |
|
|
2017
Q2 | – | Sell |
-121
| Closed | -$29K | – | 2975 |
|
|
2017
Q1 | $29K | Buy |
121
+8
| +7% | +$1.92K | ﹤0.01% | 2836 |
|
|
2016
Q4 | $31K | Sell |
113
-36
| -24% | -$9.88K | ﹤0.01% | 2841 |
|
|
2016
Q3 | $33K | Buy |
149
+4
| +3% | +$886 | ﹤0.01% | 2857 |
|
|
2016
Q2 | $56K | Buy |
+145
| New | +$56K | ﹤0.01% | 2959 |
|
|
2015
Q2 | – | Sell |
-134
| Closed | -$303K | – | 3117 |
|
|
2015
Q1 | $303K | Buy |
134
+26
| +24% | +$58.8K | ﹤0.01% | 2608 |
|
|
2014
Q4 | $111K | Buy |
108
+3
| +3% | +$3.08K | ﹤0.01% | 2946 |
|
|
2014
Q3 | $111K | Buy |
105
+1
| +1% | +$1.06K | ﹤0.01% | 2917 |
|
|
2014
Q2 | $261K | Buy |
104
+27
| +35% | +$67.8K | ﹤0.01% | 2680 |
|
|
2014
Q1 | $146K | Sell |
77
-4
| -5% | -$7.58K | ﹤0.01% | 2861 |
|
|
2013
Q4 | $173K | Buy |
81
+1
| +1% | +$2.14K | ﹤0.01% | 2864 |
|
|
2013
Q3 | $180K | Sell |
80
-1
| -1% | -$2.25K | ﹤0.01% | 2820 |
|
|
2013
Q2 | $140K | Buy |
+81
| New | +$140K | ﹤0.01% | 3151 |
|